This inventor holds 1 USPTO granted patent. Top assignee: Ambrx, Inc.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Wiliam M Keefe: Innovator in Modified FGF-21 Polypeptides
Introduction
Wiliam M Keefe is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of biotechnology, particularly in the development of modified polypeptides. His work focuses on innovative methods of treatment that utilize these modified polypeptides.
Latest Patents
Wiliam M Keefe holds a patent for "Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acids." This patent highlights the potential uses of modified FGF-21 polypeptides, which are crucial for advancing therapeutic applications.
Career Highlights
Keefe is associated with Ambrx, Inc., a company that specializes in the development of protein therapeutics. His role at Ambrx has allowed him to explore and expand the possibilities of polypeptide modifications in medical treatments.
Collaborations
Wiliam M Keefe has collaborated with notable colleagues such as Vadim Kraynov and Thomas P Cujec. These partnerships have contributed to the advancement of research and innovation in their respective fields.
Conclusion
Wiliam M Keefe's work in modified FGF-21 polypeptides represents a significant advancement in biotechnology. His contributions continue to pave the way for new treatment methodologies and innovations in the medical field.